← Leaderboards
Jingjing Sun
University Of Pittsburgh At Pittsburgh
$1,673,423
Attributed
$1,673,423
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $643.6K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,673,423 · 3
By mechanism
R01$713,259 · 1
P20$561,810 · 1
R21$398,354 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Richard A Steinman$17,934,207
- Hassane M Zarour$16,372,397
- Candace S Johnson$18,922,226
- Thomas Edward Smithgall$26,440,514
- Song Li$19,394,480
Others in their field
Other Emerging Leaders on “Drug Combinations”
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Emmanuel Aja Oga · Research Triangle Institute$16,110,065
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,277,646
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
Drug CombinationsIn VivoTumor GrowthNanocarrierSafetyCytotoxicityTreatment EfficacyTumorPenetrationBiological AvailabilityFormulationPolymersPropertyBiodistributionMalignant NeoplasmsPharmaceutical PreparationsHydrophilicityHydrophobicityImmuneNanoformulationPatient Derived Xenograft ModelDrug KineticsCancer ModelCombined Modality Therapy
Grant awards (6)
Ultra-Small Epigenetic-Regulating Nanocarrier for Enhanced Synthetic Lethal Therapy$350,518
R01 · FY2025 · CA · contact PI
Ultra-Small Epigenetic-Regulating Nanocarrier for Enhanced Synthetic Lethal Therapy$362,741
R01 · FY2024 · CA · contact PI
Development of Biodegradable Nanocarrier for Improved Co-delivery of PARPi and DNMTi$280,905
P20 · FY2024 · GM · contact PI
Development of Biodegradable Nanocarrier for Improved Co-delivery of PARPi and DNMTi$280,905
P20 · FY2023 · GM · contact PI
Tumor-permeable nanoparticles for enhanced pancreatic cancer immunochemotherapy$179,655
R21 · FY2022 · CA · contact PI
Tumor-permeable nanoparticles for enhanced pancreatic cancer immunochemotherapy$218,699
R21 · FY2021 · CA · contact PI